Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
, 386, 22-7

Clinical Efficacy of Reversible and Selective Inhibitors of Monoamine Oxidase A in Major Depression

Affiliations
Comparative Study

Clinical Efficacy of Reversible and Selective Inhibitors of Monoamine Oxidase A in Major Depression

E S Paykel. Acta Psychiatr Scand Suppl.

Abstract

This article reviews efficacy studies of the reversible selective inhibitor of monoamine oxidase A (MAO-A) moclobemide, which has now received extensive evaluation. Placebo-controlled trials have shown it clearly to be effective. In comparisons with tricyclic and similar antidepressants and with serotonin reuptake inhibitors, it has been found of equal efficacy to these standard drugs. Because of previous suggestions that older MAO inhibitors are particularly effective in depressions characterized as atypical, the effects in subtypes are of particular interest. The evidence indicates that moclobemide is effective in typical severe depression with melancholia rather than being limited to less typical subtypes.

Similar articles

See all similar articles

Cited by 5 PubMed Central articles

Publication types

MeSH terms

LinkOut - more resources

Feedback